A joint US-Russian training session of FDA and RosZdravNadzor (Russian equivalent of FDA) with the goal of sharing experience of FDA inspectors with their Russian colleagues has just been completed in Moscow.
We are pleased to announce that Cromos Pharma was chosen as a CRO for the purposes of this mock inspection. An ongoing clinical study currently managed by Cromos Pharma was selected as a showcase. A detailed review of study-related documentation and processes, including data collection, workflow patterns, accountability and reporting was performed by both agencies.
"We are extremely proud to have been selected for this very useful exercise" said Cromos Pharma's CEO, Dr. Vladimir Bogin. "Simultaneous endorsement by both agencies is a great appreciation of the quality assurance procedures that we have put in place".
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.